EP2260050A1 - Procédé amélioré de purification du sucralose - Google Patents
Procédé amélioré de purification du sucraloseInfo
- Publication number
- EP2260050A1 EP2260050A1 EP09726608A EP09726608A EP2260050A1 EP 2260050 A1 EP2260050 A1 EP 2260050A1 EP 09726608 A EP09726608 A EP 09726608A EP 09726608 A EP09726608 A EP 09726608A EP 2260050 A1 EP2260050 A1 EP 2260050A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- sucralose
- chloride
- organic solvent
- acylate
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004376 Sucralose Substances 0.000 title claims abstract description 128
- 235000019408 sucralose Nutrition 0.000 title claims abstract description 128
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 title claims abstract description 126
- 238000000746 purification Methods 0.000 title claims description 15
- 238000000034 method Methods 0.000 claims abstract description 72
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 52
- 230000008569 process Effects 0.000 claims abstract description 52
- 239000003960 organic solvent Substances 0.000 claims abstract description 46
- 239000007864 aqueous solution Substances 0.000 claims abstract description 41
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical class Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000011780 sodium chloride Chemical class 0.000 claims abstract description 26
- 239000000243 solution Substances 0.000 claims abstract description 25
- 238000000605 extraction Methods 0.000 claims abstract description 24
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 18
- 238000005192 partition Methods 0.000 claims abstract description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 64
- 239000002904 solvent Substances 0.000 claims description 50
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 22
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 20
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 18
- 230000015572 biosynthetic process Effects 0.000 claims description 16
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 238000003786 synthesis reaction Methods 0.000 claims description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 10
- 229910001514 alkali metal chloride Inorganic materials 0.000 claims description 9
- 229910001617 alkaline earth metal chloride Inorganic materials 0.000 claims description 9
- 235000019270 ammonium chloride Nutrition 0.000 claims description 9
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 9
- YKYONYBAUNKHLG-UHFFFAOYSA-N propyl acetate Chemical compound CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 claims description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- -1 wo-propyl acetate Chemical compound 0.000 claims description 7
- 238000001704 evaporation Methods 0.000 claims description 6
- 230000008020 evaporation Effects 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 5
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229940090181 propyl acetate Drugs 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 229940072049 amyl acetate Drugs 0.000 claims description 3
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 claims description 3
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 claims description 3
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropyl acetate Chemical compound CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims 1
- 238000010979 pH adjustment Methods 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- 238000005660 chlorination reaction Methods 0.000 description 19
- 239000012535 impurity Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 14
- 150000003839 salts Chemical class 0.000 description 14
- 239000012071 phase Substances 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 239000011347 resin Substances 0.000 description 12
- 229920005989 resin Polymers 0.000 description 12
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 235000014633 carbohydrates Nutrition 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 238000002425 crystallisation Methods 0.000 description 9
- 230000008025 crystallization Effects 0.000 description 9
- 239000003513 alkali Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 238000010791 quenching Methods 0.000 description 8
- 150000003511 tertiary amides Chemical class 0.000 description 8
- 238000013459 approach Methods 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 230000000171 quenching effect Effects 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 125000001309 chloro group Chemical group Cl* 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- QQVDYSUDFZZPSU-UHFFFAOYSA-M chloromethylidene(dimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)=CCl QQVDYSUDFZZPSU-UHFFFAOYSA-M 0.000 description 5
- 230000020176 deacylation Effects 0.000 description 5
- 238000005947 deacylation reaction Methods 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000000638 solvent extraction Methods 0.000 description 5
- 241000894007 species Species 0.000 description 5
- FFWSICBKRCICMR-UHFFFAOYSA-N 5-methyl-2-hexanone Chemical compound CC(C)CCC(C)=O FFWSICBKRCICMR-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000012527 feed solution Substances 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 4
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 3
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- FACOTAQCKSDLDE-YKEUTPDRSA-N [(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-3-chloro-4,5-dihydroxyoxan-2-yl]methyl acetate Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](COC(=O)C)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 FACOTAQCKSDLDE-YKEUTPDRSA-N 0.000 description 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 150000003445 sucroses Chemical class 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- FEWLNYSYJNLUOO-UHFFFAOYSA-N 1-Piperidinecarboxaldehyde Chemical compound O=CN1CCCCC1 FEWLNYSYJNLUOO-UHFFFAOYSA-N 0.000 description 2
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 2
- NQBXSWAWVZHKBZ-UHFFFAOYSA-N 2-butoxyethyl acetate Chemical compound CCCCOCCOC(C)=O NQBXSWAWVZHKBZ-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 2
- 241000244489 Navia Species 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 241000779819 Syncarpia glomulifera Species 0.000 description 2
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 2
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 238000007257 deesterification reaction Methods 0.000 description 2
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 2
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- LCEDQNDDFOCWGG-UHFFFAOYSA-N morpholine-4-carbaldehyde Chemical compound O=CN1CCOCC1 LCEDQNDDFOCWGG-UHFFFAOYSA-N 0.000 description 2
- 229940094933 n-dodecane Drugs 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 239000001739 pinus spp. Substances 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 125000000185 sucrose group Chemical group 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 2
- 229940036248 turpentine Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- BPQOIESVQZIMHQ-UGDNZRGBSA-N (2r,3r,4s,5s,6s)-2-[(2r,3s,4s,5s)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-6-(chloromethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@H](O)[C@@H](CCl)O[C@@]1(CCl)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BPQOIESVQZIMHQ-UGDNZRGBSA-N 0.000 description 1
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical group CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- NOGFHTGYPKWWRX-UHFFFAOYSA-N 2,2,6,6-tetramethyloxan-4-one Chemical compound CC1(C)CC(=O)CC(C)(C)O1 NOGFHTGYPKWWRX-UHFFFAOYSA-N 0.000 description 1
- HOSGXJWQVBHGLT-UHFFFAOYSA-N 6-hydroxy-3,4-dihydro-1h-quinolin-2-one Chemical group N1C(=O)CCC2=CC(O)=CC=C21 HOSGXJWQVBHGLT-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 229940043232 butyl acetate Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229950005499 carbon tetrachloride Drugs 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- RXFZQWIYCJKAMJ-UHFFFAOYSA-N chloromethylidene(dimethyl)azanium Chemical class C[N+](C)=CCl RXFZQWIYCJKAMJ-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000002147 dimethylamino group Chemical class [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000010931 ester hydrolysis Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N ethylene glycol dimethyl ether Natural products COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000008123 high-intensity sweetener Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 229940078552 o-xylene Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000007971 pharmaceutical suspension Substances 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 229940074411 xylene Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
Definitions
- the present invention relates to an improvement in the sucralose purification process, especially to one stage thereof, and provides sucralose when so purified.
- Sucralose, 4,r,6'-trichloro-4,r,6'-trideoxygalactosucrose a sweetener with a sweetness intensity several hundred times that of sucrose, is derived from sucrose by replacing the hydroxyl groups in the 4, I 1 , and 6' positions with chlorine.
- Synthesis of sucralose is technically challenging because of the need to selectively replace specific hydroxyl groups with chlorine atoms, while preserving other hydroxyl groups including a highly reactive primary hydroxyl group. Numerous approaches to this synthesis have been developed. See, e.g., U.S. Patent Nos. 4,362,869; 4,826,962; 4,980,463; and 5,141,860, which are expressly incorporated by reference herein.
- sucralose typically results in the concomitant synthesis of a range of chlorinated sucrose moieties which need to be separated and removed from the target molecule (sucralose) during the manufacturing process.
- the sucralose containing feed stream is subjected to a number of purification steps, of which solvent extraction is one purification process typically employed for the removal of species less and more hydrophobic than sucralose itself.
- U.S. Patent No. 4,405,654 which is expressly incorporated by reference herein, for example, relates to a process for the synthesis of a related compound, 1 ',4',6'- trichloro-r,4',6'-trideoxysucrose. After the deacetylation of a pentaacetate precursor, the reaction mixture is purified by column chromatography on silica gel. The product is eluted from the silica gel with ethyl acetate.
- U.S. Patent No. 4,980,463 which is expressly incorporated by reference herein, relates to a process in which sucralose is produced by KOH treatment of a methanol solution of sucralose-6-benzoate.
- the methanol is removed by evaporation, and the residue is dissolved in water.
- the aqueous solution is extracted three times with separate one-quarter volumes of ethyl acetate.
- the combined organic extracts are concentrated and then back extracted with water to recover sucralose present in the ethyl acetate.
- the combined aqueous portions are concentrated and treated with a decolorizing agent. Additional concentration permits crystallization of the sucralose.
- the recovered crystals have a reported purity of 99.6%.
- U.S. Patent No. 5,034,551 which is expressly incorporated by reference herein, relates to a similar process in which a base is used to hydrolyze a solution of sucralose-6- benzoate in methanol. The methanol is removed by evaporation, and the sucralose- containing residue is dissolved in water. This solution is extracted three times with separate one-quarter volumes of ethyl acetate. The remaining aqueous layer is decolorized with charcoal and concentrated, and the sucralose is allowed to crystallize.
- 5,498,709 which is expressly incorporated by reference herein, relates to solvents that may be used to extract sucralose from the aqueous brine produced by alkaline hydrolysis of a 6-acyl ester precursor compound.
- Possible solvents include methyl acetate, ethyl acetate, methyl ethyl ketone, methyl isobutyl ketone, methyl isoamyl ketone, methylene chloride, chloroform, diethyl ether, and methyl tertiary butyl ether.
- Ethyl acetate is presented as a suitable solvent for reasons of extraction selectivity, ease of recycling, and toxicological safety.
- U.S. Patent No. 5,498,709 also relates to a process in which the aqueous solution remaining after ester hydrolysis of sucralose precursors is concentrated and then sucralose is isolated by three sequential extractions with ethyl acetate or other suitable solvent. The extracts may then be combined, and optionally washed with water to remove any dimethylformamide remaining prior to recovering the sucralose by concentration and crystallization.
- This patent also relates to processes in which sucralose contained in the aqueous brine obtained after alkaline deesterification is extracted into a solvent not miscible with brine, such as dichloromethane, chloroform, 2-butanone, cyclohexanone, or ethyl acetate.
- the organic extracts may then be back extracted with water to transfer the sucralose back into the aqueous phase.
- This aqueous solution may then be decolorized and concentrated, and the resulting purified sucralose is recovered by crystallization. This approach yields a relatively impure material.
- U.S. Patent No. 5,530,106 which is expressly incorporated by reference herein, relates to an extractive process for a crude sucralose solution obtained after alkaline hydrolysis of sucralose-6-acetate and subsequent neutralization.
- the aqueous sucralose solution is extracted with water saturated ethyl acetate. Some impurities are selectively partitioned to the organic phase by this extraction. Subsequently, the ethyl acetate phase is backwashed with water in order to recover a portion of the sucralose that had also partitioned into the organic phase.
- the aqueous solution and the aqueous backwash are combined, concentrated and decolorized, and the sucralose is recovered by crystallization from the aqueous phase.
- U.S. Patent No. 7,049,435 which is expressly incorporated by reference herein, relates to methods for removing impurities from a composition comprising sucralose and impurities in a first solvent comprising the steps of performing a liquid extraction of the composition with a second immiscible solvent to effect removal of the impurities into the second solvent and performing a second extraction of the composition with a third immiscible solvent to effect the transfer of the sucralose into the third solvent and the retention of the impurities in the first solvent.
- the present invention provides an improvement in the solvent extraction of sucralose or a sucralose-6-acylate from an aqueous solution containing it.
- this solvent extraction we have observed that the partition coefficient of the sucralose or sucralose-6-acylate between the aqueous solution and the extraction solvent is relatively unfavorable and have now surprisingly discovered that this is due to the presence of dimethylammonium chloride (DMAHCl) and that the effect may be ameliorated by increasing the ratio of NaCl to DMAHCl.
- DMAHCl dimethylammonium chloride
- the exact value of the distribution coefficient (K) is a function of the wt% NaCl, the wt% DMAHCl and their relative amounts. This fact can be used to control the value of k by varying the amounts of these salts dissolved in the aqueous phase. Specifically, by increasing the ratio of sodium chloride to DMAHCl, extraction of sucralose or sucralose-6-acylate into the organic phase can be enhanced.
- one embodiment of the invention relates to a process for the extraction of sucralose or a sucralose-6-acylate from an aqueous solution containing at least said sucralose or said sucralose-6-acylate, other chlorinated saccharides, dimethylammonium chloride, and a further chloride selected from the group consisting of alkali metal chlorides, ammonium chloride and alkaline earth metal chlorides, into an organic solvent for said sucralose or said sucralose-6-acylate by contacting said organic solvent with said solution to extract said sucralose or said sucralose-6-acylate into the organic solvent, in which the ratio of said further chloride to dimethyl ammonium chloride in said aqueous solution is increased prior to or during said contact so as to increase the partition coefficient of said sucralose or said sucralose-6-acylate into said organic solvent.
- Another embodiment of the present invention relates to a process for the purification of sucralose from a feed stream from the synthesis of sucralose, in which the feed stream is subjected to a series of purification steps, at least one of the steps comprising: extracting sucralose from an aqueous solution containing at least sucralose, other chlorinated saccharides, dimethylammonium chloride, and a further chloride selected from the group consisting of alkali metal chlorides, ammonium chloride and alkaline earth metal chlorides, into an organic solvent for sucralose by contacting said organic solvent with said solution to extract sucralose into the organic solvent, in which the ratio of said further chloride to dimethylammonium chloride in said aqueous solution is increased prior to or during said contact so as to increase the partition coefficient of sucralose into said organic solvent.
- a process for the production of sucralose from a feed stream from the synthesis of sucralose-6-acylate in which the feed stream is subjected to a series of purification steps and the purified sucralose-6-acylate is then deacylated to give sucralose, at least one of the purification steps comprising: extracting sucralose-6-acylate from an aqueous solution containing at least sucralose-6-acylate, other chlorinated saccharides, dimethylammonium chloride, and a further chloride selected from the group consisting of alkali metal chlorides, ammonium chloride and alkaline earth metal chlorides, into an organic solvent for sucralose-6-acylate by contacting said organic solvent with said solution to extract sucralose-6-acylate into the organic solvent, in which the ratio of said further chloride to dimethylammonium chloride in said aqueous solution is increased prior to or during said contact so as to increase the partition coefficient of sucralose-6-acylate into said organic
- the invention provides a process for the extraction of sucralose or sucralose-6-acylate from an aqueous solution containing at least said sucralose or said sucralose-6-acylate, other chlorinated saccharides, dimethylammonium chloride, and a further chloride selected from the group consisting of alkali metal chlorides, ammonium chloride and alkaline earth metal chlorides, into an organic solvent for said sucralose or said sucralose-6-acylate, which comprises the steps:
- Figure 1 shows the effect of the ratio of NaCl to DMAHCl (all other parameters being kept constant) on the predicted distribution coefficient (Pred K).
- Aromatic as used herein includes compounds containing cyclic structures with resonant conjugated double bonds such as, for example, benzene, toluene, or xylene.
- Backwash includes an extractive step in which a second solvent phase remaining after its use to extract a first solvent is re-extracted with a small portion of the first solvent. This provides a means for recovering valuable materials such as sucralose or other species that have partially partitioned into the second solvent which may be employed to semiselectively remove impurities.
- the backwash solution may be combined with the first solvent, so that the recovery of the valuable product such as sucralose or other species may be maximized in the first solvent.
- the backwash solution optionally may be concentrated prior to its addition to the first solvent.
- Crystals as used herein includes processes in which crystals are obtained from a solution. The initiation of crystal formation may be spontaneous, or it may require the addition of seed crystals. As used herein, “crystallization” also describes the situation in which a solid or liquid material is dissolved in a solvent to yield a solution which is then rendered saturated or supersaturated so as to obtain crystals. Also, included in the term “crystallization” are the ancillary processes of filtering or centrifuging the crystals, dewatering the crystals, washing the crystals with one or more solvents, drying the crystals, and harvesting the final product so obtained.
- “Feed mixture” as used herein includes any mixture of compounds that results from any synthetic process for sucralose. Includes mixtures of sucralose and any and all impurities.
- “Impurity” as used herein includes compounds other than sucralose and includes products of any number of processes for synthesizing sucralose that are not sucralose.
- “Impurity” includes any monochloro-, dichloro-, tetrachloro-, and pentachloro-derivative of sucrose and any other disaccharide or trisaccharide derived from sucrose, sucralose, or their constituent monosaccharides, as well as any trichloro-derivative other than sucralose itself, whether present in free form or as esters of carboxylic acids.
- Impurity includes any of the halogenated sugar derivatives, such as dichlorosucrose acetate, 6, 1 ',6'-trichlorosucrose, 4,6,6'-trichlorosucrose, 4, 1 ' ⁇ o'-tetrachlorogalactotagatose, 4,l',6'-trichlorogalactosucrose-6-acetate, 4,6,1',6 '-tetrachlorogalactosucrose, 4,1'- dichlorogalactosucrose, 3',6'-dichloroanhydrosucrose, 4,6 '-dichlorogalactosucrose, l',6'- dichlorosucrose, 6,6'-dichlorosucrose, 4,l',6'-trichlorosucrose, 4,6,6'- trichlorogalactosucrose, 4,l',5'-trichlorogalactosucrose-6
- solvent as used herein includes a liquid that can dissolve or substantially disperse another substance.
- EP 0409549 discloses a process for the chlorination of a sucrose-6-acylate in a tertiary amide reaction vehicle to produce a sucralose-6-acylate, such as sucralose-6- acetate.
- a large excess of a chlorination agent, such as phosgene is used in this process.
- the excess chlorination agent is quenched using a suitable base, thereby forming the chloride salt of the base.
- the reaction solvent is, as seems usual, dimethylformamide, some of the solvent also may react with the base to produce dimethyl ammonium chloride.
- the resulting product stream thus comprises a sucralose-6-acylate, the tertiary amide reaction vehicle, water, and salts.
- the sucralose-6-acylate is then deacylated to give sucralose.
- the reaction mixture is purified, with the aim of reducing the content of salts and DMAHCl.
- this deacylation step may also result in the formation of DMAHCl.
- the base used is sodium hydroxide
- the salt formed is sodium chloride.
- other bases may be used, for example other alkali metal hydroxides, alkaline earth metal hydroxides or ammonium hydroxide, so that the salt is an alkali metal chloride, an alkaline earth metal chloride or ammonium chloride.
- the aqueous feed solution which is the starting material for the process of the present invention thus contains, in addition to sucralose or sucralose-6-acylate, various impurities derived from side reactions, sodium or another chloride and dimethylammonium chloride.
- various impurities derived from side reactions sodium or another chloride and dimethylammonium chloride.
- greater or lesser adjustments may be needed to the NaCl: DMAHCl ratio. Since it is necessary to increase this ratio, this may be achieved either by adding more of the sodium or other chloride or by removing dimethylammonium chloride.
- one useful method of removing the DMAHCl is first to adjust the pH, if necessary, to form free dimethylamine, and then to evaporate off this dimethylamine under vacuum. It has generally been found most convenient to raise the pH to a value of at least 10, and more suitably about 11 , to form free DMA from the DMAHCl. A vacuum is then applied to the reaction medium to strip off the DMA - removal of the DMA may be enhanced by raising the temperature to volatilize the DMA.
- Another method of removing DMAHCl employs a resin. For example, this may be carried out as follows:
- a strong cation resin such as DOW HCRS or Purolite C 120E
- a strong cation resin such as DOW HCRS or Purolite C 120E
- the partially desalted filtrate may be diluted to lower viscosity and enhance fiowability.
- the resin may be regenerated with either dilute caustic or 8-12% NaCl.
- the DMAHCl is removed, sufficient is preferably removed to reduce its concentration in the feed solution to a value not greater than 20,000 ppm (on sample), more preferably not greater than 1,000 ppm.
- the NaCl: DMAHCl ratio is altered, it is preferably increased to a value of from 10:1 to 100:1, more preferably from 10:1 to 25:1.
- the aqueous solution Prior to the extraction step, it is desirable that the aqueous solution should be evaporated, or otherwise treated, to increase the dry solids content, e.g. to a level of from 15% to 65%, more preferably from 30% to 55%.
- the choice of solvent is determined by the relative solubilities of sucralose and the principal impurities in the organic solvent and in the aqueous feed stream, as well as such other factors as flammability, ease of recycling within the process, environmental concerns, toxicity, and cost.
- the organic solvent can be intentionally saturated with water before use in the extraction step. Mixtures of organic solvents can be used. Solvents contemplated for use as the organic solvent include those that are immiscible with water and in which halogenated sucrose derivatives, such as sucralose, are readily soluble.
- solvents that are partially soluble in a first solvent such as water, an aqueous solution, or other solvent in which halogenated sucrose derivatives are readily soluble, but in which the second solvent still forms a separate phase when mixed with the first solvent in proper ratios and under proper conditions.
- a first solvent such as water, an aqueous solution, or other solvent in which halogenated sucrose derivatives are readily soluble
- Typical organic solvents include, but are not limited to, methyl acetate, ethyl acetate, methyl ethyl ketone, methyl ⁇ so-butyl ketone, methyl z ' s ⁇ -amyl ketone, methylene chloride, chloroform, diethyl ether, methyl t-butyl ether, ⁇ -pentane, n-hexane, n-heptane, rc-octane, isooctane, 1,1,1-trichloroethane, n-dodecane, white spirit, turpentine, cyclohexane, propyl acetate, butyl acetate, amyl acetate, carbon tetrachloride, xylene, toluene, benzene, trichloroethylene, 2-butoxyethanol acetate (butyl CELLOSOLVE® acetate), ethylene dich
- the first organic solvent preferably comprises methyl acetate, ethyl acetate, w ⁇ -propyl acetate, n-propyl acetate, n-butyl acetate, amyl acetate, methyl ethyl ketone, methyl ⁇ o-butyl ketone, methyl iso- amyl ketone, methylene chloride, chloroform, or n-butanol, either as a single solvent, or -l ias a mixed solvent with these solvents, or with other solvents from the first list.
- the first solvent more preferably comprises ethyl acetate, zso-propyl acetate, n-propyl acetate, n- butyl acetate, methyl zso-butyl ketone, or n-butanol, either as a single solvent, or as a mixed solvent with these solvents, or with other solvents from the first or second list.
- Ethyl acetate is the most preferred solvent.
- the volume ratio of the organic solvent to the aqueous feed solution is commonly from 2: 1 to 5 : 1 , more commonly from 3:1 to 4 : 1 , in order to optimize the extraction.
- the extraction may be carried out by any means known in the art for liquid-liquid extraction.
- these include methods of agitation in a standard vessel, followed by settling and decanting, continuous column extractors, and/or continuous mixing and decanting.
- Batch, continuous and continuous countercurrent equipment can be used in the present invention. Examples of this equipment include, but are not limited to, any Karr reciprocating plate column (Koch Inc., Kansas City, Mo.), any Scheibel Column (Koch Inc., Kansas City, Mo.), any packed column, any pulsed packed column, any bank of mixer-settlers, any bank of mixers and centrifugal separators, and any centrifugal counter current extractors (e.g., extractors manufactured by Robatel Inc., Pittsfield Mass.).
- first extraction backwash of the first extraction, and second extraction
- the acylate group may be any such group suitable for protecting the 6-position of sucrose during a chlorination reaction; however, the acetate and benzoate are preferred.
- the process of the present invention is applied to a sucralose-6-acylate, the compound must be deacylated to afford sucralose.
- Methods for performing the deacylation are well known in the art. For example, the method disclosed in US 6,890,581, incorporated herein in its entirety by reference, can be used.
- sucralose purified according to the method of the present invention can, if desired, by further purified.
- Suitable techniques include liquid/liquid extraction and crystallization. Suitable techniques are disclosed in US 7,049,435 and US 6,998,480, both of which are incorporated herein in their entirety by reference.
- Selective protection of the 6-hydroxyl of sucrose can be carried out by reaction of sucrose with a carboxylic acid anhydride, such as acetic anhydride or benzoic anhydride, in an anhydrous polar aprotic solvent in the presence of an organotin-based acylation promoter, at a temperature and for a period of time sufficient to produce the sucrose-6- ester.
- a carboxylic acid anhydride such as acetic anhydride or benzoic anhydride
- an anhydrous polar aprotic solvent in the presence of an organotin-based acylation promoter
- sucrose-6-acetate When sucrose-6-acetate is prepared, 1 ,3-diacetoxy-l ,1 ,3,3- tetrabutyldistannoxane, for example, can be used as the organotin-based acylation promoter and acetic anhydride as the carboxylic acid anhydride.
- acetic anhydride Preparation of sucrose- 6-esters is disclosed in, for example, O'Brien, U.S. Pat. No. 4,783,526; Navia, U.S. Pat. No. 4,950,746; Simpson, U.S. Pat. No. 4,889,928; Neiditch, U.S. Pat. No. 5,023,329; Walkup, U.S. Pat. No.
- the chlorination process comprises the following steps.
- a reaction mixture is prepared comprising the sucrose-6-ester, a tertiary amide, and at least seven molar equivalents of a chlorination agent.
- the sucrose-6-ester can be added in a feed stream that comprises about 20 wt% to about 40 wt% of the sucrose- 6-ester.
- the ratio by weight of tertiary amide to total carbohydrate in the reaction mixture may be about 5 : 1 to about 12:1.
- a preformed chloro formiminium salt such as (chloromethylene)dimethylammonium chloride (Arnold's reagent), can be used.
- (Chloromethylene)dimethylammonium chloride can be prepared, for example, by the reaction of phosgene with N,N-dimethyl formamide. Typically, the molar ratio of the (chloromethylene)dimethylammonium salt to the sucrose-6-ester is about 7:1 to about 11 :1.
- chlorination agent refers to any compound that can be used to form a chloroformiminium salt or Vilsmeier reagent, or that can convert the hydroxyl groups of a sucrose-6-ester to chloro groups.
- chlorination agents that can be used include, for example, phosgene, phosphorus oxychloride, phosphorus pentachloride, thionyl chloride, sulfuryl chloride, oxalyl chloride, trichloromethyl chloroformate (“diphosgene”), bis(trichloromethyl) carbonate (“triphosgene”), and methane sulfonylchloride.
- Tertiary amides that can be used include, for example, N,N- dimethyl formamide (DMF), N-formyl piperidine, N-formyl morpholine, and N ,N- diethyl formamide.
- N,N-dimethyl formamide When N,N-dimethyl formamide is used as the tertiary amide, it can also be used as the reaction solvent.
- Co-solvents can be used at up to about 80 vol% or more of the liquid phase of the reaction medium. Useful co-solvents are those which are both chemically inert and which provide sufficient solvent power to enable the reaction to become essentially homogeneous at the monochlorination stage, for example toluene, o-xylene, 1,1,2-trichloroethane, 1 ,2-diethoxyethane, di ethylene glycol dimethyl ether.
- Quenching of the reaction mixture restores the hydroxyl groups at the 2, 3, 3', and 4 1 positions and forms the sucralose-6-ester.
- the reaction mixture can be quenched by the addition of about 0.5 to about 2.0 molar equivalents, typically about 1.0 to about 1.5 molar equivalents, of alkali relative to the amount of chlorination agent used in the reaction.
- An aqueous solution of an alkali metal hydroxide, such as sodium or potassium hydroxide; an aqueous slurry of an alkaline earth metal hydroxide, such as calcium hydroxide; or aqueous ammonium hydroxide can be used to quench the reaction.
- an aqueous solution of an alkali metal hydroxide such as aqueous sodium hydroxide, that contains about 5 wt% to about 35 wt%, typically about 8 wt% to about 20 wt%, and preferably about 10 wt% to about 12 wt% can be used.
- an alkali metal hydroxide such as aqueous sodium hydroxide
- quenching can be carried out by addition of alkali to the reaction mixture, by the dual stream process, or by the circulated process.
- pH and temperature are controlled during addition of the alkali.
- Quenching is typically carried out at a pH between about 8.5 to about 10.5 and at a temperature of about 0 0 C to about 6O 0 C.
- the pH should not be permitted to rise above about 10.5 during the course of the quenching reaction.
- quenching is carried out by slow addition of the aqueous alkali with simultaneous slow addition of the chlorination reaction material into a reaction vessel.
- the chlorination reaction mixture and aqueous alkali are simultaneously added slowly until the desired quantity of chlorination reaction mixture has been added. Further aqueous alkali is added until the desired pH is reached. Then the temperature and pH are maintained at the desired levels for the remainder of the reaction.
- This process can be a batch or continuous process.
- quenching is carried out by circulating the chlorination reaction mixture from a vessel through a circulation loop. Chlorination reaction mixture and aqueous alkali are added slowly into this circulation loop. Sufficient aqueous alkali is added until the desired pH is reached. Then the temperature and pH are maintained at the desired levels for the remainder of the reaction.
- This process can be a batch or continuous process.
- reaction mixture can be neutralized by the addition of aqueous acid, for example aqueous hydrochloric acid.
- aqueous acid for example aqueous hydrochloric acid.
- the resulting mixture comprises sucralose 6-ester, other carbohydrate including chlorinated carbohydrate impurities, unreacted tertiary amide, and salts in an aqueous solvent in which the predominant solvent is water.
- the sucralose-6-ester containing aqueous feed stream typically comprises both sucralose and sucralose-6-ester.
- Methods for hydrolyzing sucralose-6-ester are disclosed, for example in Catani, U.S. Pat. Nos. 5,977,349, 6,943,248, 6,998,480, and 7,049,435; Vernon, U.S. Pat. No. 6,890,581 ; El Kabbani, U.S. Pat. Nos. 6,809,198, and 6,646,121 ; Navia, U.S. Pat. Nos. 5,298,61 1 and 5,498,709, and U.S. Pat. Pub. 2004/0030124; Liesen, U.S. Pat. Pub.
- sucralose-6-ester can be hydrolyzed to sucralose by raising the pH of the reaction mixture to about 1 l ⁇ l at a temperature and for a time sufficient to effect removal of the protecting group, and (b) the tertiary amide is removed by, for example, steam stripping. Either step (a) or step (b) can be carried first.
- conversion of sucralose-6-ester to sucralose can be carried in methanol containing sodium methoxide.
- a trans-esterification reaction occurs that forms sucralose and the methyl ester of the acid, for example methyl acetate when the sucralose-6-ester is sucralose-6-acetate.
- the methyl ester of the acid can be removed by distillation, and the resulting sucralose containing product dissolved in water.
- the process of the invention is useful in the preparation of sucralose.
- the invention provides an increased yield of crystalline sucralose from a feed of an impure aqueous sucralose solution such as one obtained by alkaline deacylation of a 6-O-acyl precursor and neutralization.
- Sucralose is a high-intensity sweetener that can be used in many food and beverage applications, as well as in other applications.
- Such applications include, for example, beverages, combination sweeteners, consumer products, sweetener products, tablet cores (Luber, U.S. Pat. No. 6,277,409), pharmaceutical compositions (Luber, U.S. Pat. No. 6,258,381 ; Roche, U.S. Pat. No. 5,817,340; and McNaIIy, U.S. Pat. No. 5,593,696), rapidly absorbed liquid compositions (Gelotte, U.S. Pat. No. 6,211,246), stable foam compositions (Gowan, Jr., U.S. Pat. No.
- a sucralose solution containing various impurities can be obtained by a number of previously disclosed processes for synthesizing sucralose, as set out above. See, e.g., U.S. Pat. No. 5,498,709.
- a 6-O-acyl sucralose derivative was deacylated and steam stripped to remove dimethylformamide remaining from the chlorination reaction. This resulted in an aqueous solution with approximately the following composition:
- a series of aqueous solutions containing DMAHCl, NaCl and sucralose were made up in water as shown in Table 1. The solutions were all clear and colorless at room temperature.
- Table 6 shows that the weight % concentrations of sodium chloride and sucralose have a positive effect on K (i.e.: the more there is of these components in the feed the higher the K value) whereas surprisingly, the weight % of DMAHCl has the opposite effect - the higher the weight % of DMAHCl, the lower K is. If these regression coefficients are used to predict the K values, a close correlation is seen, as shown in Table 7:
- DMAHCl is also a salt and may have been expected to show a similar effect to NaCl. However, surprisingly it shows the opposite effect. The reason for this is not clear.
- the accompanying drawing shows the effect of the ratio of NaCl to DMAHCl (all other parameters being kept constant) on the predicted distribution coefficient (Pred K).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4206808P | 2008-04-03 | 2008-04-03 | |
PCT/US2009/039105 WO2009124116A1 (fr) | 2008-04-03 | 2009-04-01 | Procédé amélioré de purification du sucralose |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2260050A1 true EP2260050A1 (fr) | 2010-12-15 |
EP2260050B1 EP2260050B1 (fr) | 2014-09-17 |
Family
ID=40940647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09726608.4A Active EP2260050B1 (fr) | 2008-04-03 | 2009-04-01 | Procédé amélioré de purification du sucralose |
Country Status (8)
Country | Link |
---|---|
US (1) | US8497367B2 (fr) |
EP (1) | EP2260050B1 (fr) |
JP (1) | JP5496181B2 (fr) |
KR (1) | KR20110003516A (fr) |
CN (1) | CN101981045B (fr) |
AR (1) | AR071580A1 (fr) |
TW (1) | TW200946686A (fr) |
WO (1) | WO2009124116A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101098971B (zh) * | 2004-12-10 | 2010-04-21 | V.B.医疗保险私人有限公司 | 有助于从含水反应混合物中选择性萃取4,1',6'三氯半乳蔗糖的盐 |
GB2469157B (en) * | 2009-03-30 | 2011-07-06 | John Kerr | Process for removing dimethylamine during sucralose production |
CN103012509B (zh) * | 2012-12-13 | 2015-04-15 | 福建科宏生物工程有限公司 | 一种分离提纯三氯蔗糖-6-乙酸酯母液的方法 |
CN109467578B (zh) * | 2018-03-14 | 2022-01-21 | 刘静 | 一种从多重母液里提取三氯蔗糖的方法 |
CN112480186A (zh) * | 2020-11-30 | 2021-03-12 | 安徽金禾实业股份有限公司 | 一种三氯蔗糖一次母液的处理方法 |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL39710A (en) | 1972-06-19 | 1975-04-25 | Imi Inst For Res & Dev | Recovery of acids from aqueous solutions by solvent extraction |
EP0031651B1 (fr) | 1979-12-20 | 1983-03-23 | TATE & LYLE PUBLIC LIMITED COMPANY | Procédé pour la préparation du 4,1',6'-trichloro-4,1',6'-tridéoxy-galactosucrose |
EP0043649B1 (fr) | 1980-07-08 | 1984-09-12 | TATE & LYLE PUBLIC LIMITED COMPANY | Procédé pour la préparation de 4,1',6'-trichloro-4,1',6'-tridésoxygalactosucrose (TGS) |
CA1183133A (fr) | 1980-10-28 | 1985-02-26 | Tate & Lyle Public Limited Company | Disaccharides chlores utilises comme edulcorants |
GB8525954D0 (en) | 1985-10-21 | 1985-11-27 | Mcneilab Inc | Chlorination of carbohydrates &c alcohols |
GB8525871D0 (en) | 1985-10-21 | 1985-11-27 | Tate & Lyle Plc | Chemical compound |
GB8622345D0 (en) | 1986-09-17 | 1986-10-22 | Tate & Lyle Plc | Sucrose derivatives |
US4950746A (en) | 1988-07-18 | 1990-08-21 | Noramco, Inc. | Process for synthesizing sucrose derivatives by regioselective reaction |
GB8822673D0 (en) | 1988-09-27 | 1988-11-02 | Tate & Lyle Plc | Selective acylation of sugars |
GB8822674D0 (en) | 1988-09-27 | 1988-11-02 | Tate & Lyle Plc | Preparation of acylated sucrose derivatives |
NZ234143A (en) | 1989-06-28 | 1991-10-25 | Mcneil Ppc Inc | Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents |
US4980463A (en) | 1989-07-18 | 1990-12-25 | Noramco, Inc. | Sucrose-6-ester chlorination |
US5089608A (en) | 1990-03-23 | 1992-02-18 | Mcneil-Ppc, Inc. | Selective 6-acylation of sucrose mediated by cyclic adducts of dialkyltin oxides and diols |
US5023329A (en) | 1990-04-23 | 1991-06-11 | Noramco, Inc. | Sucrose-6-ester production process |
US5034551A (en) | 1990-04-23 | 1991-07-23 | Noramco, Inc. | Process for recovery of organotin esters from reaction mixtures containing the same and re-use of the recovered organotin compounds |
US5470969A (en) | 1990-08-27 | 1995-11-28 | Mcneil-Ppc, Inc. | Catalyzed sucrose-6-ester process |
NZ240818A (en) | 1990-12-14 | 1993-08-26 | Mcneil Ppc Inc | Liquid sucralose concentrate compositions containing preservative, buffer and liquid |
GB9110931D0 (en) | 1991-05-21 | 1991-07-10 | Tate & Lyle Plc | Process for the preparation of sucrose 6-esters |
US5272137A (en) | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
US5270071A (en) | 1992-06-18 | 1993-12-14 | Mcneil-Ppc, Inc. | Reduced calorie fruit spreads |
US5397588A (en) | 1992-06-18 | 1995-03-14 | Mcneil-Ppc, Inc. | Reduced calorie fruit spreads |
US5354902A (en) | 1992-10-26 | 1994-10-11 | Mcneil-Ppc, Inc. | Stabilized sorbic acid or salt thereof |
CA2110313C (fr) | 1992-12-01 | 2004-10-26 | Edward John Roche | Compositions pharmaceutiques contenant un compose de guanidothiazole et antiacides |
IL108340A (en) | 1993-03-04 | 1996-10-16 | Innova Sa | Citric acid extraction |
US5298611A (en) | 1993-03-12 | 1994-03-29 | Mcneil-Ppc, Inc. | Sucralose pentaester production |
US5530106A (en) * | 1993-03-12 | 1996-06-25 | Mcneil-Ppc, Inc. | Recovery of sucralose intermediates |
CA2121435C (fr) | 1993-04-16 | 2002-01-22 | Sheila M. Ratnaraj | Suspension pharmaceutique aqueuse et methode de preparation |
CA2128820A1 (fr) | 1993-07-27 | 1995-01-28 | Walter G. Gowan, Jr. | Forme pharmaceutique a desintegration rapide et methode de preparation |
US5674522A (en) | 1993-10-07 | 1997-10-07 | Mcneil-Ppc, Inc. | Beverage concentrate for drug delivery |
US5498709A (en) | 1994-10-17 | 1996-03-12 | Mcneil-Ppc, Inc. | Production of sucralose without intermediate isolation of crystalline sucralose-6-ester |
US5593696A (en) | 1994-11-21 | 1997-01-14 | Mcneil-Ppc, Inc. | Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders |
US5902628A (en) | 1996-11-14 | 1999-05-11 | Pepsico., Inc. | Beverage with reduction of lingering sweet aftertaste of sucralose |
BR9807377B1 (pt) | 1997-02-13 | 2009-12-01 | processo para separação de fase lìquida de uma sacarose clorada a partir de uma mistura de reação de sacarose clorada. | |
AU753587B2 (en) | 1997-11-14 | 2002-10-24 | Johnson & Johnson Consumer Companies, Inc. | Highly flavored dental floss |
EP1109461B1 (fr) | 1998-07-07 | 2004-10-06 | McNEIL-PPC, INC. | Amelioration de l'effet edulcorant de la sucralose |
UA72220C2 (uk) | 1998-09-08 | 2005-02-15 | Байоенджініерінг Рісорсиз, Інк. | Незмішувана з водою суміш розчинник/співрозчинник для екстрагування оцтової кислоти, спосіб одержання оцтової кислоти (варіанти), спосіб анаеробного мікробного бродіння для одержання оцтової кислоти (варіанти), модифікований розчинник та спосіб його одержання |
US6090401A (en) | 1999-03-31 | 2000-07-18 | Mcneil-Ppc, Inc. | Stable foam composition |
US6211246B1 (en) | 1999-06-10 | 2001-04-03 | Mcneil-Ppc, Inc. | Rapidly absorbed liquid compositions |
US6277409B1 (en) | 2000-02-11 | 2001-08-21 | Mcneil-Ppc, Inc. | Protective coating for tablet |
US6258381B1 (en) | 2000-02-11 | 2001-07-10 | Mcneil-Ppc, Inc. | Tablet and process for making the same |
GB2365424B (en) | 2000-07-31 | 2002-06-26 | Tate & Lyle Plc | An improved method for the synthesis of sucrose-6-esters |
EP1339728B1 (fr) | 2000-11-17 | 2013-02-27 | Tate & Lyle Technology Limited | Composition de sucralose amelioree et son procede de preparation |
US6926810B2 (en) | 2001-03-15 | 2005-08-09 | A. E. Staley Manufacturing Co. | Process for obtaining an organic acid from an organic acid ammonium salt, an organic acid amide, or an alkylamine organic acid complex |
US6984293B2 (en) | 2001-03-15 | 2006-01-10 | Tate & Lyle Ingredients | Azeotropic distillation of cyclic esters of hydroxy organic acids |
US6998480B2 (en) | 2002-03-08 | 2006-02-14 | Tate & Lyle Public Limited Company | Process for improving sucralose purity and yield |
US7049435B2 (en) | 2002-03-08 | 2006-05-23 | Tate & Lyle Public Limited Company | Extractive methods for purifying sucralose |
US6890581B2 (en) | 2002-04-05 | 2005-05-10 | Tate & Lyle Public Limited Company | Methods for buffer stabilized aqueous deacylation |
US20040030124A1 (en) | 2002-08-06 | 2004-02-12 | Catani Steven J. | Process for recovering chlorosucrose compounds |
DE10260085A1 (de) | 2002-12-19 | 2004-07-01 | Basf Ag | Verfahren zum Extrahieren von 2-Keto-L-gulonsäure (KGS) aus einem polaren, vorzugsweise wässrigen Lösungsmittel |
JP2006516148A (ja) | 2002-12-19 | 2006-06-22 | ビーエーエスエフ アクチェンゲゼルシャフト | 極性の、好ましくは水性の溶媒から2−ケト−l−グロン酸(kga)を抽出する方法 |
US6943248B2 (en) | 2003-04-30 | 2005-09-13 | Tate & Lyle Public Limited Company | Crystalline form of sucralose, and method for producing it |
US6723877B1 (en) | 2003-06-16 | 2004-04-20 | Air Products And Chemicals, Inc. | Dimethylformamide synthesis via reactive distillation of methyl formate and dimethylamine |
CN1312164C (zh) * | 2003-09-23 | 2007-04-25 | 李宝才 | 单酯法合成三氯蔗糖的方法 |
WO2005090376A1 (fr) | 2004-03-19 | 2005-09-29 | Pharmed Medicare Private Limited | Procede ameliore de production de saccharose traite au chlore |
NZ550064A (en) | 2004-03-19 | 2010-06-25 | V B Medicare Private Ltd | An improved process for producing chlorinated sucrose (sucralose) |
CN101098971B (zh) | 2004-12-10 | 2010-04-21 | V.B.医疗保险私人有限公司 | 有助于从含水反应混合物中选择性萃取4,1',6'三氯半乳蔗糖的盐 |
WO2006061856A2 (fr) | 2004-12-10 | 2006-06-15 | Pharmed Medicare Private Limited | Procede ameliore destine a la purification de 6 acetyl 4, 1', 6' trichlorogalactosucrose et 4, 1', 6' trichlorogalactosucrose par chromatographie sur du gel de silice silanisee |
US20060188629A1 (en) | 2005-01-21 | 2006-08-24 | Greg Liesen | Method for the purification of sucralose |
US20060205936A1 (en) | 2005-03-14 | 2006-09-14 | Sl Laboratories, Llc | Chlorination of Sucrose-6-esters |
KR20080016826A (ko) | 2005-06-01 | 2008-02-22 | 팜드 메디케어 프리베이트 리미티드 | 용매 추출에 의한 염소화 수크로스 유도체의 정제 방법 |
US20060276639A1 (en) | 2005-06-01 | 2006-12-07 | Healthy Brands, Llc | Conversion of sucralose-6-ester to sucralose |
GB2441919A (en) | 2005-06-06 | 2008-03-19 | Pharmed Medicare Pvt Ltd | Method for purification of chlorinated sucrose derivatives from reaction mixture by chromatography |
CN101263153A (zh) | 2005-08-30 | 2008-09-10 | 法马德医疗保险私人有限公司 | 基于疏水亲和色谱层析生产氯化蔗糖的方法 |
US20070100139A1 (en) | 2005-10-31 | 2007-05-03 | Healthy Brands, Llc | Methods for chlorinating sucrose-6-ester |
US7741477B2 (en) | 2006-01-10 | 2010-06-22 | Alembic Limited | Process for purification of sucralose |
CN100418976C (zh) | 2006-04-03 | 2008-09-17 | 广州科宏食品添加物有限公司 | 一种三氯蔗糖的制备方法 |
US20090312538A1 (en) | 2006-07-06 | 2009-12-17 | Alembic Limited | process for the preparation of sucralose of high purity |
US20080227971A1 (en) | 2007-01-19 | 2008-09-18 | Leinhos Duane A | Deacylation of sucralose-6-acylates |
-
2009
- 2009-03-30 US US12/413,955 patent/US8497367B2/en active Active
- 2009-04-01 WO PCT/US2009/039105 patent/WO2009124116A1/fr active Application Filing
- 2009-04-01 JP JP2011503135A patent/JP5496181B2/ja not_active Expired - Fee Related
- 2009-04-01 KR KR1020107024663A patent/KR20110003516A/ko not_active Application Discontinuation
- 2009-04-01 CN CN200980110920.6A patent/CN101981045B/zh active Active
- 2009-04-01 EP EP09726608.4A patent/EP2260050B1/fr active Active
- 2009-04-01 TW TW098110885A patent/TW200946686A/zh unknown
- 2009-04-03 AR ARP090101193A patent/AR071580A1/es unknown
Non-Patent Citations (1)
Title |
---|
See references of WO2009124116A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2260050B1 (fr) | 2014-09-17 |
JP5496181B2 (ja) | 2014-05-21 |
US8497367B2 (en) | 2013-07-30 |
KR20110003516A (ko) | 2011-01-12 |
CN101981045B (zh) | 2014-12-03 |
CN101981045A (zh) | 2011-02-23 |
AR071580A1 (es) | 2010-06-30 |
TW200946686A (en) | 2009-11-16 |
JP2011516491A (ja) | 2011-05-26 |
US20090299054A1 (en) | 2009-12-03 |
WO2009124116A1 (fr) | 2009-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2160641C (fr) | Production de sucralose sans isolation intermediaire du sucralose-6-ester cristallise | |
US5298611A (en) | Sucralose pentaester production | |
US20060188629A1 (en) | Method for the purification of sucralose | |
AU2005332295A1 (en) | Conversion of sucralose-6-ester to sucralose | |
WO2011045566A1 (fr) | Procédé basse température à solvant unique pour produire un sucrose-6-ester | |
GB2474310A (en) | A process for the production of sucrose-6-ester | |
US8497367B2 (en) | Sucralose purification process | |
PT2646452E (pt) | Cloração de carboidratos e de derivados de carboidrato | |
JP2009542625A (ja) | 高純度スクラロースの改良製造法 | |
US20090299055A1 (en) | Purification of Sucralose Containing Feed Streams for Sucralose Crystallization | |
US20090281295A1 (en) | Crystallization of sucralose from sucralose-containing feed streams | |
EP2260049B1 (fr) | Effet de la concentration d'hydrate de carbone sur l'efficacité de l'extraction de sucralose | |
US20090259036A1 (en) | Extraction of less polar impurities from sucralose containing aqueous feed streams | |
CA2205535C (fr) | Production de pentaester de sucralose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20100910 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: JANSEN, ROBERT Inventor name: WALKER, GORDON Inventor name: KERR, JOHN Inventor name: BAIADA, ANTHONY |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: TATE & LYLE TECHNOLOGY LIMITED |
|
17Q | First examination report despatched |
Effective date: 20131029 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20140328 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 687664 Country of ref document: AT Kind code of ref document: T Effective date: 20141015 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602009026717 Country of ref document: DE Effective date: 20141030 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141218 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141217 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20140917 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 687664 Country of ref document: AT Kind code of ref document: T Effective date: 20140917 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150117 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150119 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602009026717 Country of ref document: DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 |
|
26N | No opposition filed |
Effective date: 20150618 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602009026717 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150401 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151103 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150430 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150430 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20151231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150401 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20090401 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140917 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230520 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240423 Year of fee payment: 16 |